Abstract:Background and aims: Viral infections are the leading cause of myocarditis. Besides acute cardiac complications, late-stage sequelae such as myocardial fibrosis may develop, importantly impacting the prognosis. Coxsackievirus B3 (CVB)-induced myocarditis in mice is the most commonly used translational model to study viral myocarditis and has provided the majority of our current understanding of the disease pathophysiology. Nevertheless, the late stages of disease, encompassing fibrogenesis and arrhythmogenesis, have been underappreciated in viral myocarditis research to date. The present study investigated the natural history of CVB-induced myocarditis in C57BL/6J mice, expanding the focus beyond the acute phase of disease. In addition, we studied the impact of sex and inoculation dose on the disease course. Methods and results: C57BL/6J mice (12 weeks old; n=154) received a single intraperitoneal injection with CVB to induce viral myocarditis, or vehicle (PBS) as control. Male mice (n=92) were injected with 5 × 105 (regular dose) (RD) or 5 × 106 (high dose) (HD) plaque-forming units of CVB, whereas female mice received the RD only. Animals were sacrificed 1, 2, 4, 8, and 11 weeks after CVB or PBS injection. Virally inoculated mice developed viral disease with a temporary decline in general condition and weight loss, which was less pronounced in female animals (P<.001). In male CVB mice, premature mortality occurred between days 8 and 23 after inoculation (RD: 21%, HD: 20%), whereas all female animals survived. Over the course of disease, cardiac inflammation progressively subsided, with faster resolution in female mice. There were no substantial group differences in the composition of the inflammatory cell infiltrates: predominance of cytotoxic T cells at day 7 and 14, and a switch from arginase1-reactive macrophages to iNOS-reactive macrophages from day 7 to 14 were the main findings. There was concomitant development and maturation of different patterns of myocardial fibrosis, with enhanced fibrogenesis in male mice. Virus was almost completely cleared from the heart by day 14. Serum biomarkers of cardiac damage and cardiac expression of remodeling genes were temporarily elevated during the acute phase of disease. Cardiac CTGF gene upregulation was less prolonged in female CVB animals. In vivo electrophysiology studies at weeks 8 and 11 demonstrated that under baseline conditions (i.e. in the absence of proarrhythmogenic drugs), ventricular arrhythmias could only be induced in CVB animals. The cumulative arrhythmia burden throughout the entire stimulation protocol was not significantly different between CVB and control groups. Conclusion: CVB inoculation in C57BL/6J mice represents a model of acute self-limiting viral myocarditis, with progression to different patterns of myocardial fibrosis. Sex, but not inoculation dose, seems to modulate the course of disease.

A viral-specific CD4+ T cell response protects female mice from Coxsackievirus B3 infection

Coxsackievirus B3 elicits a sex-specific CD8+ T cell response which protects female mice

Monocytic Myeloid-Derived Suppressor Cells from Females, but Not Males, Alleviate Cvb3-Induced Myocarditis by Increasing Regulatory and Cd4(+)Il-10(+) T Cells

Differential Macrophage Polarization in Male and Female Balb/C Mice Infected with Coxsackievirus B3 Defines Susceptibility to Viral Myocarditis

The natural history of CVB3 myocarditis in C57BL/6J mice: an extended in-depth characterization

Sex Hormone Contributes to Sexually Dimorphic Susceptibility in CVB3-Induced Viral Myocarditis Via Modulating IFN-γ+ NK Cell Production.

Distinct Th17 inductions contribute to the gender bias in CVB3-induced myocarditis.

Relationship Between Th Immune Bias and Viral Myocarditis Induced by Coxsackie Virus Type B3

Mt10 Vaccine Protects Diversity Outbred Mice from CVB3 Infection by Producing Virus-Specific Neutralizing Antibodies and Diverse Antibody Isotypes

Coxsackievirus B3 infection reduces female mouse fertility

An intranasal attenuated Coxsackievirus B3 vaccine induces strong systemic and mucosal immunity against CVB3 lethal challenge

A live-attenuated mutant CVB3 vaccine virus protects against multiple coxsackievirus B infections

Sex differences in vaccine induced immunity and protection against

Initial Weight and Virus Dose: Two Factors Affecting the Onset of Acute Coxsackievirus B3 Myocarditis in C57bl/6 Mouse-A Histopathology-Based Study

Mucosal-associated invariant T cell responses differ by sex in COVID-19

Assessing how biological sex effects tissue-resident memory T cell responses to influenza infection

Mapping and role of T cell response in SARS-CoV-2–infected mice

Low Hepatitis B Virus-Specific T-Cell Response in Males Correlates with High Regulatory T-Cell Numbers in Murine Models

Pathogenesis of coxsackievirus B3-induced myocarditis: role of macrophage migration inhibitory factor.

Sex Differences in Expression of Pro-Inflammatory Markers and miRNAs in a Mouse Model of CVB3 Myocarditis

Viral Dilated Cardiomyopathy with Heart Failure by CVB3 Inoculation in Balb/c Mice